Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perspectives on clinical trials for gastrointestinal malignancies.
Eng C, Roach N, Longabaugh M, Fisher G. Eng C, et al. Among authors: roach n. Am Soc Clin Oncol Educ Book. 2015:40-3. doi: 10.14694/EdBook_AM.2015.35.40. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993140 Free article. No abstract available.
Losing "Losing the Battle With Cancer".
Ellis LM, Blanke CD, Roach N. Ellis LM, et al. Among authors: roach n. JAMA Oncol. 2015 Apr;1(1):13-4. doi: 10.1001/jamaoncol.2014.188. JAMA Oncol. 2015. PMID: 26182295 No abstract available.
Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015.
Allegra CJ, Rumble RB, Hamilton SR, Mangu PB, Roach N, Hantel A, Schilsky RL. Allegra CJ, et al. Among authors: roach n. J Clin Oncol. 2016 Jan 10;34(2):179-85. doi: 10.1200/JCO.2015.63.9674. Epub 2015 Oct 5. J Clin Oncol. 2016. PMID: 26438111 Review.
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort study.
Bendell JC, Bekaii-Saab TS, Cohn AL, Hurwitz HI, Kozloff M, Tezcan H, Roach N, Mun Y, Fish S, Flick ED, Dalal D, Grothey A. Bendell JC, et al. Among authors: roach n. Oncologist. 2012;17(12):1486-95. doi: 10.1634/theoncologist.2012-0190. Epub 2012 Sep 26. Oncologist. 2012. PMID: 23015662 Free PMC article.
Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational model.
Manne S, Kashy D, Albrecht T, Wong YN, Flamm AL, Benson AB 3rd, Miller SM, Fleisher L, Buzaglo J, Roach N, Katz M, Ross E, Collins M, Poole D, Raivitch S, Miller DM, Kinzy TG, Liu T, Meropol NJ. Manne S, et al. Among authors: roach n. Med Decis Making. 2014 May;34(4):454-63. doi: 10.1177/0272989X13511704. Epub 2013 Nov 18. Med Decis Making. 2014. PMID: 24246567 Free PMC article.
A Blueprint to Advance Colorectal Cancer Immunotherapies.
Le DT, Hubbard-Lucey VM, Morse MA, Heery CR, Dwyer A, Marsilje TH, Brodsky AN, Chan E, Deming DA, Diaz LA Jr, Fridman WH, Goldberg RM, Hamilton SR, Housseau F, Jaffee EM, Kang SP, Krishnamurthi SS, Lieu CH, Messersmith W, Sears CL, Segal NH, Yang A, Moss RA, Cha E, O'Donnell-Tormey J, Roach N, Davis AQ, McAbee K, Worrall S, Benson AB. Le DT, et al. Among authors: roach n. Cancer Immunol Res. 2017 Nov;5(11):942-949. doi: 10.1158/2326-6066.CIR-17-0375. Epub 2017 Oct 16. Cancer Immunol Res. 2017. PMID: 29038296
Financial Concerns About Participation in Clinical Trials Among Patients With Cancer.
Wong YN, Schluchter MD, Albrecht TL, Benson AB 3rd, Buzaglo J, Collins M, Flamm AL, Fleisher L, Katz M, Kinzy TG, Liu TM, Manne S, Margevicius S, Miller DM, Miller SM, Poole D, Raivitch S, Roach N, Ross E, Meropol NJ. Wong YN, et al. Among authors: roach n. J Clin Oncol. 2016 Feb 10;34(5):479-87. doi: 10.1200/JCO.2015.63.2463. Epub 2015 Dec 23. J Clin Oncol. 2016. PMID: 26700120 Free PMC article.
148 results